Cortexyme, a company focusing on treatments for degenerative diseases, entered into a deal to acquire Novosteo, which plays in the rare disease space. Once the deal is finalized, the merged companies will operate under the name Quince Therapeutics and trade under the ticker symbol QNCX.
If you are not happy with the results below please do another search
50 search results for:
Pfizer Inc. said on May 10 the company will pay $11.6 billion to buy Biohaven Pharmaceutical Holding Co., making a big bet on its ability to boost sales of the top-selling pill in a new class of migraine drugs.
A lawyer for two Ohio counties said CVS Health Corp., Walgreens Boots Alliance Inc. and Walmart Inc. should fund an $878 million plan to address the opioid crisis there, as a first-of-its-kind trial got underway to determine the pharmacy chains’ contribution.
Ashfield Engage, part of UDG Healthcare, acquired PROPENSITY4 – a ‘smart data’ organization and leader in the healthcare insights and analytics arena.
CrowdPharm, a full-service agency with the largest network of global talent in healthcare, was named to Inc. Magazine’s annual Best Workplaces list. The list results from a comprehensive measurement of American companies that have excelled in creating exceptional workplaces and company culture, whether operating in a physical or virtual facility.
Underscoring an investment in the growth, development and engagement of their talent, WPP company CMI Media Group and NMSDC certified diverse supplier Compas announced the launch of University Learning Services, a dedicated team that will benefit the agency’s ability to scale and create even more dynamic career pathing.
Novavax Inc.’s shares plunged nearly 20 percent in premarket trading on May 10 due to uncertainty over global demand for the company’s COVID-19 vaccine following a slow start to deliveries.
Twist Bioscience and Astellas have entered into a research collaboration and exclusive option license agreement to identify potential therapeutic antibodies which would help to reduce tumor microenvironment-mediated immunosuppression.
Eisai and Biogen completed the rolling submission of a Biologics License Application for their proposed Alzheimer’s disease drug to the U.S. Food and Drug Administration.
The World Health Organization’s European chief said on May 10 that at least 3,000 people had died in Ukraine since Russia’s invasion in February because they had been unable to access treatments for chronic diseases.